77.78 M
About Bioasis Technologies Inc.
Sector
Industry
CEO
Deborah A. Rathjen
Website
Headquarters
New Haven
Founded
2006
ISIN
CA09064N1033
FIGI
BBG000VNSZF0
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIOAF is 0.0060 USD — it has decreased by 37.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioasis Technologies Inc. stocks are traded under the ticker BIOAF.
Bioasis Technologies Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOAF stock is 60.00% volatile and has beta coefficient of −0.15. Check out the list of the most volatile stocks — is Bioasis Technologies Inc. there?
BIOAF earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.02 USD resulting in a 50.00% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about Bioasis Technologies Inc. earnings.
Bioasis Technologies Inc. revenue for the last quarter amounts to 3.13 M USD despite the estimated figure of 191.87 K USD. In the next quarter revenue is expected to reach 231.50 K USD.
Yes, you can track Bioasis Technologies Inc. financials in yearly and quarterly reports right on TradingView.
BIOAF stock has fallen by 20.00% compared to the previous week, the month change is a 4.76% fall, over the last year Bioasis Technologies Inc. has showed a 66.48% decrease.
Today Bioasis Technologies Inc. has the market capitalization of 288.31 K, it has decreased by 0.09% over the last week.
No, BIOAF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioasis Technologies Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioasis Technologies Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioasis Technologies Inc. stock shows the sell signal. See more of Bioasis Technologies Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.